George Bloom is receiving new interest in an old paper

University of Virginia biology professor George Bloom is receiving revived interest lately in an old paper. Eleven years ago, he was part of a research team that illuminated the Alzheimer’s brain target that a new and exciting – but not yet approved – drug called Donanemab now acts upon.

Click here, to read full story.

Photo credit: George Bloom is a biologist and UVA Health researcher who has studied the target Donanemab acts upon. (UVA Health photo)